Display options
Cite
Ortiz-Gutiérrez F, Sánchez-Minutti L, Martínez-Herrera JF, et al. Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer. Pol J Microbiol. 2021;70(4):501-509doi: 10.33073/pjm-2021-047.
Ortiz-Gutiérrez, F., Sánchez-Minutti, L., Martínez-Herrera, J. F., Torres-Escobar, I. D., Pezzat-Said, E. B., Márquez-Domínguez, L., & Grandes-Blanco, A. I. (2021). Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer. Polish journal of microbiology, 70(4), 501-509. https://doi.org/10.33073/pjm-2021-047
Ortiz-Gutiérrez, Felipe, et al. "Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer." Polish journal of microbiology vol. 70,4 (2021): 501-509. doi: https://doi.org/10.33073/pjm-2021-047
Ortiz-Gutiérrez F, Sánchez-Minutti L, Martínez-Herrera JF, Torres-Escobar ID, Pezzat-Said EB, Márquez-Domínguez L, Grandes-Blanco AI. Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer. Pol J Microbiol. 2021 Dec;70(4):501-509. doi: 10.33073/pjm-2021-047. Epub 2021 Dec 23. PMID: 35003280; PMCID: PMC8702602.
Copy Download .nbib Format: NLM
Share it on

Pol J Microbiol. 2021 Dec;70(4):501-509. doi: 10.33073/pjm-2021-047. Epub 2021 Dec 23.

Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer.

Polish journal of microbiology

Felipe Ortiz-Gutiérrez, Lilia Sánchez-Minutti, José F Martínez-Herrera, Indiana D Torres-Escobar, Elias B Pezzat-Said, Luis Márquez-Domínguez, Amado I Grandes-Blanco

Affiliations

  1. Programa Institucional de Biomedicina Molecular, Escuela Nacional de Medicina y Homeopatía. Instituto Politécnico Nacional, CDMX, México.
  2. Laboratorio de Procesos Biotecnológicos, Universidad Politécnica de Tlaxcala, Tlaxcala, México.
  3. Oncología Médica y Neoplasias de Torax y Medicina Interna Centro de Cáncer Hospital ABC, CDMX, México.
  4. Facultad de Medicina, Benemerita Universidad Autónoma de Puebla, Puebla, México.
  5. Departamento de Investigación en Salud SSEP, Puebla, México.
  6. Laboratorio de Biología Molecular y Virología, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Metepec, Puebla, México.
  7. Facultad de Ciencias de la Salud, Licenciatura en Nutrición, Universidad Autónoma de Tlaxcala, Tlaxcala, México.

PMID: 35003280 PMCID: PMC8702602 DOI: 10.33073/pjm-2021-047

Abstract

Infections caused by the human immunodeficiency virus (HIV) and human papillomavirus (HPV) cause thousands of deaths worldwide each year. So far, there has been no consensus on whether there is a direct relationship between the incidence of neoplasms and the immunosuppression caused by HIV that could help understand if coinfection increases the likelihood of cervical cancer. The objective of the study was to identify the presence of genetic variants of HPV in a group of HIV-positive women and their possible association with cervical cancer. Cervical samples were taken from HIV-positive patients for cytological analysis to identify the HPV genotype by polymerase chain reaction (PCR) and sequencing. The most prevalent L1 capsid protein mutations in the HPV genotype were analyzed

© 2021 Felipe Ortiz-Gutiérrez et al.

Keywords: cervical cancer; human immunodeficiency virus; human papillomavirus; polymorphism

Conflict of interest statement

Conflict of interest The authors do not report any financial or personal connections with other persons or organizations, which might negatively affect the contents of this publication and/or claim au

References

  1. Gynecol Oncol. 2018 Oct;151(1):102-110 - PubMed
  2. Asian Pac J Cancer Prev. 2014;15(23):10061-6 - PubMed
  3. J Biol Chem. 2007 Oct 26;282(43):31803-11 - PubMed
  4. Virus Res. 2017 Mar 2;231:119-127 - PubMed
  5. Int J Cancer. 2001 Feb 1;91(3):412-20 - PubMed
  6. Sex Transm Infect. 2001 Aug;77(4):248-54 - PubMed
  7. Curr Opin HIV AIDS. 2009 Jan;4(1):52-6 - PubMed
  8. Infect Agent Cancer. 2008 Feb 28;3:3 - PubMed
  9. Br J Cancer. 2007 May 7;96(9):1480-3 - PubMed
  10. Clin Microbiol Infect. 2019 Dec;25(12):1560.e1-1560.e7 - PubMed
  11. Gene. 2019 Mar 30;690:99-112 - PubMed
  12. Clin Investig. 1994 Mar;72(4):283-7 - PubMed
  13. PLoS One. 2016 Oct 20;11(10):e0163965 - PubMed
  14. Curr Opin Infect Dis. 2009 Apr;22(2):191-7 - PubMed
  15. Biomed Res Int. 2020 Jun 16;2020:4945608 - PubMed
  16. J Infect Dis. 2009 May 15;199(10):1514-24 - PubMed
  17. Infect Dis Obstet Gynecol. 2012;2012:384758 - PubMed
  18. Cancer. 2001 Apr 25;93(2):111-4 - PubMed
  19. Mem Inst Oswaldo Cruz. 2017 Oct;112(10):728-731 - PubMed
  20. Cancer. 2018 Dec 1;124(23):4520-4528 - PubMed
  21. HIV Med. 2012 Jul;13(6):372-8 - PubMed
  22. BMC Cancer. 2017 Aug 8;17(1):531 - PubMed
  23. PLoS One. 2019 Apr 18;14(4):e0215222 - PubMed
  24. Sex Transm Dis. 2019 Aug;46(8):532-539 - PubMed
  25. Virology. 2018 Mar;516:86-101 - PubMed
  26. J Clin Microbiol. 1997 Jun;35(6):1304-10 - PubMed
  27. PLoS One. 2019 Feb 27;14(2):e0212516 - PubMed
  28. J Infect Dis. 2009 Jun 15;199(12):1851-61 - PubMed
  29. J Clin Virol. 2013 Dec;58(4):696-702 - PubMed
  30. Int J Health Sci (Qassim). 2016 Jul;10(3):327-38 - PubMed
  31. Medicine (Baltimore). 2020 Feb;99(9):e19273 - PubMed
  32. Infect Agent Cancer. 2012 Dec 03;7(1):34 - PubMed
  33. Nucleic Acids Res. 2012 Jul;40(Web Server issue):W471-7 - PubMed
  34. J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):168-75 - PubMed
  35. PLoS One. 2019 Sep 4;14(9):e0221334 - PubMed
  36. Lancet. 1998 Jun 20;351(9119):1833-9 - PubMed
  37. J Reprod Med. 1996 Aug;41(8):586-90 - PubMed
  38. J Med Virol. 2008 May;80(5):847-55 - PubMed
  39. Nucleic Acids Res. 2015 Jul 1;43(W1):W174-81 - PubMed
  40. Acta Cytol. 2015;59(2):121-32 - PubMed
  41. Infect Dis Obstet Gynecol. 2009;2009:810596 - PubMed
  42. J Med Virol. 2015 May;87(5):871-84 - PubMed
  43. J Infect Dis. 2001 Sep 1;184(5):547-51 - PubMed
  44. Mem Inst Oswaldo Cruz. 2010 Mar;105(2):144-8 - PubMed
  45. Int J Cancer. 2018 May 1;142(9):1952-1958 - PubMed
  46. Nucleic Acids Res. 2007;35(10):3375-82 - PubMed
  47. JAMA. 1991 Jun 5;265(21):2809-10 - PubMed
  48. Mutat Res. 1994 Mar 1;305(2):293-301 - PubMed
  49. Anticancer Res. 2018 May;38(5):3079-3084 - PubMed
  50. AIDS. 2006 Nov 28;20(18):2337-44 - PubMed
  51. Rev Invest Clin. 2017 Sep-Oct;69(5):262-269 - PubMed
  52. JAMA. 2001 Apr 4;285(13):1736-45 - PubMed
  53. J Natl Cancer Inst. 2005 Mar 16;97(6):425-32 - PubMed
  54. Ginecol Obstet Mex. 2001 Apr;69:137-42 - PubMed

Publication Types